- Home
- SOTK vs MIRA Comparison
SOTK vs MIRA Comparison
Compare SOTK & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOTK | MIRA |
|---|---|---|
| Founded | 1975 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 53.2M |
| IPO Year | 1995 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SOTK | MIRA |
|---|---|---|
| Price | $4.22 | $1.20 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.1K | ★ 123.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.31 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $20,504,381.00 | N/A |
| Revenue This Year | $4.02 | N/A |
| Revenue Next Year | $10.95 | N/A |
| P/E Ratio | $51.75 | ★ N/A |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $3.23 | $0.81 |
| 52 Week High | $5.15 | $2.45 |
Technical Indicators
Market Signals| Indicator | SOTK | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 45.57 |
| Support Level | $3.87 | $1.13 |
| Resistance Level | $4.30 | $1.35 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 44.33 | 46.68 |
Price Performance
Historical ComparisonAbout SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.